|
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
|
9 Months Ended |
|
Apr. 06, 2013
|
Mar. 31, 2012
|
| Cash flows from operating activities: |
|
|
| Net income (loss) |
$ (56,670) |
$ 8,701 |
| Adjustments to reconcile net income (loss) to cash provided (used) by operating activities: |
|
|
| Non-cash compensation expense |
1,977 |
1,627 |
| Depreciation and amortization |
16,039 |
15,098 |
| Non-cash charge for asset impairment |
2,910 |
391 |
| Net loss (gain) on disposal of property |
869 |
(481) |
| Tax benefit from exercise of stock options and awards |
88 |
279 |
| Excess tax benefit from exercise of stock options and awards |
(1) |
(120) |
| Deferred rent and other lease incentives |
(43) |
173 |
| Deferred income taxes |
28,401 |
(3,539) |
| Changes in operating assets and liabilities: |
|
|
| Receivables |
387 |
(217) |
| Inventories |
(2,714) |
(826) |
| Prepaid expenses and other |
(968) |
600 |
| Accounts payable |
1,502 |
(265) |
| Accrued liabilities |
(3,497) |
1,202 |
| Long term income taxes payable |
(1,342) |
27 |
| Net cash provided (used) by operating activities |
(13,062) |
22,650 |
| Cash flows from investing activities: |
|
|
| Purchase of property and equipment |
(20,782) |
(17,478) |
| Insurance proceeds from property and equipment |
0 |
763 |
| Purchase of intangible assets |
0 |
(27) |
| Purchase of marketable securities |
(54,545) |
(69,750) |
| Proceeds from sales of investment securities |
92,251 |
86,771 |
| Net cash provided by investing activities |
16,924 |
279 |
| Cash flows from financing activities: |
|
|
| Proceeds from issuance of common stock |
133 |
1,165 |
| Excess tax benefit from exercise of stock options and awards |
1 |
120 |
| Cash dividends paid |
(6,242) |
(6,318) |
| Purchase of common stock |
(21,229) |
0 |
| Net cash used by financing activities |
(27,337) |
(5,033) |
| Net increase (decrease) in cash and equivalents |
(23,475) |
17,896 |
| Effect of exchange rate changes on cash |
332 |
166 |
| Cash and equivalents: |
|
|
| Beginning of period |
104,982 |
95,177 |
| End of period |
$ 81,839 |
$ 113,239 |